Latest Report puts real-world evidence solutions at $6.22bn in 2026, with data sets and market-access uses growing fastest — though patchy methodology standards and a skills shortage still limit ...
Patronus Biotech, a biotechnology company that develops next-generation vaccines to address unmet global needs, today announced that its Phase I first-in-human clinical trial NCT07831226 of three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results